Micro-X Ltd.ASX: MX1

MX1 - Quarterly Activities Report & Appendix 4C

· Issued by Micro-X Ltd.

Filed with ASX · · 12 pages · English

Summary by 6ix AI

The report indicates a significant increase in product sales receipts compared to the previous quarter and outlines a strategic reset focusing on medical CT commercialization. The company has implemented cost-saving measures and received multiple purchase orders for its Rover units, reflecting a growing sales pipeline. Looking ahead, Micro-x expects to benefit from contracted development receipts and a growing Rover sales pipeline, with a commercial release of RoverX planned.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Micro-X Ltd. on 6ix

Story so far

Earlier from Micro-X

Later from Micro-X

All Micro-X news releases